ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

Abstracts Of Papers Presented By Breast Cancer Task Force

September 17, 1976

In Brief: Million, Donaldson Head ASTRO; James Weese Moves To Presbyterian; Ginder Replaces Kennedy

November 9, 1990

Ohio Center Helps Women Stop Smoking, Reduce Cervical Cancer Risk

October 29, 2004

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

NIH Study Sections Use New Scoring Procedure

July 3, 1998